Track topics on Twitter Track topics that are important to you
Visgenyx Ltd is a spin-off company of Tartu University offering the following services: development of transgenic animals, gene targeting, construction of animal models, phenotype analysis, different behavoural studies of laboratory animals, customized animal research, in-situ-hybridization and immunochemistry of whole mount embryos and tissues, radiology and binding, microdialysis.
PO Box 229
Phone: +372 5 155431
Fax: +372 7 477131
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
Visgenyx Ltd was founded in 1999 by Prof. Alar Karis and Prof. Eero Vasar, both scientists at the University of Tartu, Estonia.An increasing demand for appropriate animal models for study of human dis...
Visgenyx Ltd is a spin-off company of Tartu University offering the following services: development of transgenic animals, gene targeting, construction of animal models, phenotype analysis, different ...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
We have published hundreds of Visgenyx Limited news stories on BioPortfolio along with dozens of Visgenyx Limited Clinical Trials and PubMed Articles about Visgenyx Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Visgenyx Limited Companies in our database. You can also find out about relevant Visgenyx Limited Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...